Intuitive Surgical Inc
- Intuitive Surgical Inc. eased 0.8% to $474.70 after the medical devices company reported first-quarter 2025 results.
Revenue surged to $2.25 billion from $1.89 billion, net income jumped to $698.4 million from $544.9 million, and diluted earnings per share rose to $1.92 from $1.51 a year ago.
The company guided fiscal 2025 worldwide da Vinci procedure growth to be between 15% and 17%, compared to 17% in 2024, including an estimated impact of tariffs of 1.7% of revenue, plus or minus 30 basis points.
Apr 23, 2025 - Intuitive Surgical rose 3.3% to $385.0 after the robotic surgical equipment maker reported better-than-expected quarterly results.
Revenue in the first quarter increased 11% to $1.89 billion from $1.70 billion, net income rose to $547.4 million from $360.8 million, and diluted earnings per share advanced to $1.51 from $1.01 a year ago.
The company placed 313 da Vinci surgical systems, compared with 312 in the first quarter of 2023, and increased its installed base by 14% to 8,887 systems from 7,779 at the end of the first quarter of 2023.
Apr 19, 2024 - Intuitive Surgical rose 4.9% to $347.0 after the medical equipment maker reported preliminary quarterly results and a stronger-than-expected fourth-quarter sales outlook.
Revenue in the fourth quarter increased 17% to $1.93 billion from $1.66 billion, and revenue in the full-year 2023 rose 14% to $7.12 billion from $6.22 billion a year ago.
The company placed 415 da Vinci surgical systems, an increase of 12% from a year ago.
In 2023, the number of da Vinci surgical systems installed increased by 8% to 1,370 from 1,264 a year ago.
Jan 10, 2024 - Intuitive Surgical, Inc fell 2.5% to $338.05 after the robotic surgery device maker reported weaker-than-expected revenue in system sales but the company met earnings expectations.
Total revenue in the second quarter increased to $1.8 billion from $1.5 billion and net income advanced to $426 million from $313.6 million and diluted earnings per share rose to $1.18 from 85 cents a year ago.
Worldwide da Vinci procedures rose 22% compared to the quarter in the previous year. During the second quarter of 2022, the company’s procedure volumes were negatively impacted by COVID-19 cases and increased hospitalizations and government interventions impacting parts of Asia, particularly China.
The compound annual growth rate between the second quarter of 2019 and the second quarter of 2023 was approximately 17%.
The company placed 331 da Vinci surgical systems, compared with 279 and grew its da Vinci surgical system installed base 13% to 8,042 systems from 7,135 in the quarter a year ago.
Jul 21, 2023 - Intuitive Surgical Inc said revenue in the first quarter increased 14% to $1.7 billion from $1.5 billion and worldwide da Vinci procedures rose 26% from a year ago.
Net income declined to $355.3 million from $365.6 million and diluted earnings per share was unchanged at $1.0.
The company installed 312 da Vinci surgical systems in the first quarter compared to 311 in the period a year ago, increasing its installed base 12% to 7,779 from 6,920 at the end of the first quarter of 2022.
Apr 19, 2023
Year | Mar | Jun | Sep | Dec | Annual | |
---|---|---|---|---|---|---|
2023 | 1.00 | 1.18 | 1.16 | - | - | |
2022 | 1 | 0.85 | 0.9 | 0.90 | 3.65 | |
2021 | 3.51 | 4.25 | 1.04 | 1.03 | 4.66 | |
2020 | 2.62 | 0.57 | 2.6 | 3.03 | 2.94 | |
2019 | 2.56 | 2.67 | 3.33 | 2.98 | 3.85 | |
2018 | 2.44 | 2.15 | 2.45 | 2.45 | 9.49 | |
2017 | 4.67 | 5.05 | 2.55 | 2.07 | 14.34 | |
2016 | 3.67 | 4.86 | 5.39 | 5.30 | 19.22 | |
2015 | 2.81 | 3.80 | 4.50 | 5.18 | 16.29 | |
2014 | 0.38 | 0.92 | 1.12 | 1.29 | 3.7 | |
2013 | 1.52 | 1.30 | 1.33 | 1.43 | 5.58 | |
2012 | 1.17 | 1.25 | 1.49 | 1.42 | 5.33 | |
2011 | 0.86 | 0.97 | 1.02 | 1.26 | 4.11 | |
2010 | 0.71 | 0.73 | 0.71 | 1.01 | 3.16 | |
2009 | 0.24 | 0.54 | 0.55 | 0.65 | 1.98 | |
2008 | 0.37 | 0.43 | 0.48 | 0.43 | 1.71 | |
2007 | 0.21 | 0.26 | 0.35 | 0.42 | 1.23 | |
2006 | 0.13 | 0.15 | 0.15 | 0.21 | 0.63 | |
2005 | 0.08 | 0.13 | 0.18 | 0.44 | 0.84 |